ProMetic's PBI-4050 Granted Orphan Drug Designation by EC for Treatment of Idiopathic Pulmonary Fibrosis

By: via Benzinga
ProMetic Life Sciences Inc. (OTC: PFSCF) announced today that an orphan drug designation status has been granted for its lead drug ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.